Advertisement
Screener

VANDA PHARMACEUTICALS INC. (VNDA) Graph

VNDA Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $50.53M; Research and development $36.95M; Selling, general and administrative $71.84M; Income tax $129.00K.
  • 2026-03-31: Revenue $51.72M; Research and development $28.43M; Selling, general and administrative $68.36M; Income tax $143.00K.
  • 2025-12-31: Revenue $57.22M*; Research and development $29.01M*; Selling, general and administrative $62.98M*; Income tax $103.19M*.
  • 2025-09-30: Revenue $56.26M; Research and development $22.56M; Selling, general and administrative $60.27M; Income tax -$5.80M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

VNDA revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Fanapt$35.99MHetlioz$5.58MNEREUS$1.03MPONVORY$7.94MRevenue$50.53MOperating income-$63.81MResearch & development$36.95MSelling, general& administrative$71.84MPre-tax income-$62.38MNet income-$62.51M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

VNDA revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Product Segments$50.53MRevenue$50.53MOperating income-$63.81MResearch & development$36.95MSelling, general& administrative$71.84MPre-tax income-$62.38MNet income-$62.51M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueResearch and developmentSelling, general and administrativeIncome taxNet income
2026-06-30$50.53M$36.95M$71.84M$129.00K-$62.51M
2026-03-31$51.72M$28.43M$68.36M$143.00K-$48.57M
2025-12-31$57.22M*$29.01M*$62.98M*$103.19M*-$141.21M*
2025-09-30$56.26M$22.56M$60.27M-$5.80M-$22.59M
2025-06-30$52.59M$21.99M$64.62M-$7.68M-$27.21M
2025-03-31$50.04M$35.71M$50.08M-$7.87M-$29.49M
2024-09-30$47.65M$16.78M$37.57M-$920.00K-$5.32M
2024-06-30$50.47M$16.66M$39.47M-$998.00K-$4.52M
2024-03-31$47.46M$21.15M$30.09M-$518.00K-$4.15M
2023-09-30$38.81M$16.60M$24.77M-$257.00K$137.00K
2023-06-30$46.06M$16.65M$28.40M$1.07M$1.52M
2023-03-31$62.50M$19.24M$36.10M$2.28M$3.25M
2022-09-30$65.32M$24.86M$29.85M$2.19M$3.27M
2022-06-30$64.39M$21.49M$33.00M$1.22M$2.57M
2022-03-31$60.19M$20.97M$40.85M-$1.13M-$6.43M
2021-09-30$70.09M$19.65M$32.46M$2.95M$7.77M
2021-06-30$67.90M$20.25M$28.35M$2.95M$9.65M
2021-03-31$62.67M$16.13M$29.80M$1.78M$8.65M
2020-12-31$67.65M(m)(m)(m)$8.19M
2020-09-30$60.31M$12.30M$34.00M$2.45M$5.95M
2020-06-30$62.21M$12.90M$33.92M$2.38M$8.71M
2020-03-31$58.00M$15.53M$37.02M$755.00K$486.00K
2019-12-31$60.93M(m)(m)(m)$4.22M
2019-09-30$59.48M$11.35M$30.22M-$88.15M$100.42M
2019-06-30$59.06M$10.95M$31.47M$18.00K$11.53M
2019-03-31$47.71M$13.28M$31.03M$10.00K-$612.00K
2018-12-31$53.04M(m)(m)(m)$10.36M
2018-09-30$49.13M$11.39M$26.05M$92.00K$7.17M
2018-06-30$47.35M$9.87M$27.96M$90.00K$4.61M
2018-03-31$43.59M$9.42M$26.82M-$2.00K$3.07M
2017-12-31$44.28M(m)(m)(m)-$1.84M
2017-09-30$41.34M$10.18M$31.12M$23.00K-$4.55M
2017-06-30$42.06M$7.65M$31.37M$7.00K-$1.53M
2017-03-31$37.41M$10.57M$30.30M$19.00K-$7.64M
2016-12-31$38.24M(m)(m)(m)-$604.00K
2016-09-30$38.48M$7.29M$21.91M$0.00-$430.00K
2016-06-30$36.03M$6.70M$24.68M$0.00-$4.62M
2016-03-31$33.26M$7.55M$29.29M$0.00-$12.36M
2015-12-31$31.85M(m)(m)(m)-$14.80M
2015-09-30$28.34M$9.97M$18.46M$0.00-$9.46M
2015-06-30$27.58M$5.95M$18.39M$0.00-$5.39M
2015-03-31$22.15M$4.48M$18.81M$0.00-$10.22M
2014-12-31$15.37M(m)(m)(m)$69.72M
2014-09-30$14.78M$3.70M$11.29M(m)-$1.43M
2014-06-30$10.86M$3.51M$28.14M(m)-$21.57M
2014-03-31$9.14M$7.26M$27.89M(m)-$26.53M
2013-12-31$8.78M(m)(m)(m)-$7.75M
2013-09-30$8.71M$8.02M$5.74M(m)-$5.41M
2013-06-30$8.32M$6.10M$5.26M(m)-$3.38M
2013-03-31$8.07M$8.11M$4.15M(m)-$4.52M
2012-12-31$7.92M(m)(m)(m)-$6.37M
2012-09-30$8.29M$10.16M(m)(m)-$5.33M
2012-06-30$8.38M$12.49M(m)(m)-$8.01M
2012-03-31$8.14M$12.18M(m)(m)-$7.96M
2011-12-31$8.37M(m)(m)(m)-$5.52M
2011-09-30$7.97M$8.17M(m)-$113.00K-$3.07M
2011-06-30$7.43M$6.00M(m)-$51.00K-$1.34M
2011-03-31$7.50M$4.27M(m)$6.00K$136.00K
2010-09-30$7.25M$4.07M(m)-$2.29M$3.18M
2010-06-30$8.29M$2.40M(m)-$37.00K$1.28M

Revenue and expense 6 month

Period endRevenueResearch and developmentSelling, general and administrativeIncome taxNet income
2026-06-30$102.25M$65.39M$140.20M$272.00K-$111.08M
2025-06-30$102.63M$57.70M$114.70M-$15.55M-$56.70M
2024-06-30$97.94M$37.81M$69.56M-$1.52M-$8.66M
2023-06-30$108.55M$35.88M$64.50M$3.35M$4.77M
2022-06-30$124.58M$42.46M$73.85M$82.00K-$3.86M
2021-06-30$130.57M$36.38M$58.14M$4.73M$18.30M
2020-06-30$120.21M$28.43M$70.94M$3.13M$9.20M
2019-06-30$106.77M$24.23M$62.50M$28.00K$10.91M
2018-06-30$90.94M$19.28M$54.78M$88.00K$7.68M
2017-06-30$79.47M$18.21M$61.67M$26.00K-$9.18M
2016-06-30$69.29M$14.25M$53.97M$0.00-$16.98M
2015-06-30$49.73M$10.42M$37.19M$0.00-$15.61M
2014-06-30$20.00M$10.78M$56.03M(m)-$48.11M
2013-06-30$16.39M$14.21M$9.41M(m)-$7.90M
2012-06-30$16.52M$24.67M(m)(m)-$15.97M
2011-06-30$14.93M$10.27M(m)-$45.00K-$1.21M
2010-06-30$20.71M$4.44M(m)$5.63M$1.81M

Revenue and expense 9 month

Period endRevenueResearch and developmentSelling, general and administrativeIncome taxNet income
2025-09-30$158.89M$80.27M$174.97M-$21.36M-$79.29M
2024-09-30$145.59M$54.59M$107.13M-$2.44M-$13.99M
2023-09-30$147.37M$52.48M$89.27M$3.09M$4.91M
2022-09-30$189.90M$67.32M$103.70M$2.27M-$586.00K
2021-09-30$200.66M$56.03M$90.60M$7.68M$26.07M
2020-09-30$180.51M$40.73M$104.94M$5.58M$15.15M
2019-09-30$166.26M$35.58M$92.72M-$88.12M$111.34M
2018-09-30$140.08M$30.67M$80.83M$180.00K$14.85M
2017-09-30$120.81M$28.39M$92.79M$49.00K-$13.73M
2016-09-30$107.77M$21.54M$75.88M$0.00-$17.41M
2015-09-30$78.08M$20.40M$55.65M$0.00-$25.07M
2014-09-30$34.79M$14.48M$67.32M(m)-$49.53M
2013-09-30$25.10M$22.23M$15.15M(m)-$13.31M
2012-09-30$24.81M$34.83M(m)(m)-$21.30M
2011-09-30$22.90M$18.44M(m)-$158.00K-$4.28M
2010-09-30$27.96M$8.52M(m)$3.34M$4.99M

Revenue and expense 12 month

Period endRevenueResearch and developmentSelling, general and administrativeIncome taxNet income
2025-12-31$216.10M$109.27M$237.95M$81.83M-$220.50M
2024-12-31$198.77M$74.43M$146.41M-$4.02M-$18.90M
2023-12-31$192.64M$76.82M$112.88M$3.83M$2.50M
2022-12-31$254.38M$85.77M$136.49M$5.03M$6.30M
2021-12-31$268.68M$75.36M$124.05M$9.21M$33.20M
2020-12-31$248.17M$55.58M$140.51M$8.32M$23.34M
2019-12-31$227.19M$48.65M$129.74M-$86.53M$115.55M
2018-12-31$193.12M$43.59M$105.75M$138.00K$25.21M
2017-12-31$165.08M$38.55M$123.84M$136.00K-$15.57M
2016-12-31$146.02M$29.16M$99.79M$104.00K-$18.01M
2015-12-31$109.92M$29.14M$84.53M$0.00-$39.87M
2014-12-31$50.16M$19.23M$84.64M$0.00$20.19M
2013-12-31$33.88M$28.50M$25.08M$0.00-$21.05M
2012-12-31$32.73M$45.76M$14.52M(m)-$28.62M
2011-12-31$31.27M$29.00M(m)-$444.00K-$9.80M
2010-12-31$35.71M$12.34M(m)$2.08M$7.19M
2009-12-31$4.55M$13.87M(m)(m)-$35.86M

Similar stocks

Stock NameCountryMarket CapPE Ratio
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Evommune, Inc. (EVMN)United States$0.320B-5.10
Upstream Bio, Inc. (UPB)United States$0.284B-2.42